Rodolfo Gutierrez

Phase I experience with first in class TnMUC1 targeted chimeric antigen receptor T-cells in patients with advanced TnMUC1 positive solid tumors.

Rodolfo Gutierrez, Payal D. Shah, Omid Hamid et al. · Journal of Clinical Oncology · 2021 · 33 citations

Life Sciences, Immunology, Oncology +17

AB928, a novel dual adenosine receptor antagonist, combined with chemotherapy or AB122 (anti-PD-1) in patients (pts) with advanced tumors: Preliminary results from ongoing phase I studies.

John D. Powderly, Paul L. de Souza, Rodolfo Gutierrez et al. · Journal of Clinical Oncology · 2019 · 32 citations

Medicine, Oncology, Pharmacology +17

Clinical activity of fianlimab (REGN3767), a human anti-LAG-3 monoclonal antibody, combined with cemiplimab (anti-PD-1) in patients (pts) with advanced melanoma.

Omid Hamid, Ding Wang, Tae Min Kim et al. · Journal of Clinical Oncology · 2021 · 29 citations

Medicine, Oncology, Pharmacology +17

The Effects of Administration of Lithium Salts and Magnesium Sulfate on the Serum Anion Gap

F J Silverstein, James R. Oster, Barry J. Materson et al. · American Journal of Kidney Diseases · 1989 · 15 citations

Medicine, Pharmacology, Pharmacotherapy +12

Cobimetinib plus vemurafenib (C+V) in patients (Pts) with solid tumors with BRAF V600E/d/k/R mutation: Results from the targeted agent and profiling utilization registry (TAPUR) study.

Funda Meric‐Bernstam, Michael Rothe, Elizabeth Garrett‐Mayer et al. · Journal of Clinical Oncology · 2022 · 13 citations

Medicine, Oncology, Pharmacology +15